What is the treatment for tonsillitis with bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The treatment for tonsillitis with bleeding requires immediate medical attention, and pain management with ibuprofen (400-600 mg every 6-8 hours) is recommended as it does not increase the risk of bleeding, according to the most recent evidence 1.

Key Considerations

  • For mild bleeding, gargling with cold water or sucking on ice chips may help temporarily.
  • Medical treatment typically includes antibiotics such as penicillin (500 mg twice daily for 10 days) or amoxicillin (500 mg three times daily for 10 days) if bacterial infection is suspected, as supported by recent studies on antibiotic duration 1.
  • Severe bleeding may require emergency care including cauterization, surgical ligation of blood vessels, or in some cases, tonsillectomy.

Management and Prevention

  • Patients should stay hydrated, rest, and avoid irritants like spicy foods, alcohol, and smoking.
  • Bleeding during tonsillitis is concerning as it may indicate severe infection, potential injury to blood vessels, or rarely, more serious conditions like peritonsillar abscess.
  • If bleeding persists or is heavy, emergency medical care should be sought immediately as significant blood loss can occur rapidly from the tonsillar region.

Evidence-Based Recommendations

  • The use of NSAIDs, such as ibuprofen, in children was not associated with an increased risk of bleeding, secondary bleeding, readmissions, or need for reoperation due to bleeding, as shown in a study involving 1747 children 1.
  • A review from the Cochrane Collaboration found that NSAIDs did not significantly increase the risk of bleeding as compared with placebo or other analgesics, and resulted in less vomiting 1.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Tonsillitis with Bleeding

  • Tonsillitis is an inflammation of the tonsils, which can be caused by viral or bacterial infections 2.
  • In cases of bacterial tonsillitis, antibiotics such as penicillin are prescribed as the first-line treatment 2, 3.
  • Spontaneous tonsillar bleeding is a rare but potentially life-threatening complication of tonsillitis, with a higher incidence in young patients and a higher mortality rate 4, 5.

Treatment Options

  • For recurrent acute pharyngo-tonsillitis, antibiotics such as clindamycin and amoxicillin with clavulanate may be effective in preventing future episodes and eradicating group A streptococci from the tonsils 6.
  • In cases of spontaneous tonsillar bleeding, a management plan should be formulated to address the potentially fatal condition 4.
  • Antibiotic treatment may be an option for patients with recurrent acute pharyngo-tonsillitis who have contraindications for tonsillectomy 6.

Specific Considerations

  • The use of dispersible tablets of amoxicillin + clavulanic acid may have a higher safety profile compared to film-coated tablets in the treatment of acute streptococcal tonsillopharyngitis 3.
  • Infectious mononucleosis is a rare cause of spontaneous tonsillar hemorrhage, and reported cases indicate an increased incidence in young patients with a higher mortality rate 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tonsillitis and Tonsilloliths: Diagnosis and Management.

American family physician, 2023

Research

Management of spontaneous tonsillar bleeding: review.

The Journal of laryngology and otology, 2010

Research

Antibiotics for recurrent acute pharyngo-tonsillitis: systematic review.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.